Here are four things to know.
1. Pfizer first said it was contemplating strategic options for the unit Oct. 10.
2. Pfizer Consumer Healthcare, which sells common over-the-counter products like Advil, Centrum and ChapStick, represents one of the biggest OTC healthcare products businesses in the world and carries a potential $15 billion-plus price tag.
3. Sources said several companies, including GlaxoSmithKline and Reckitt Benckiser, have already expressed interest in the consumer health unit. Other potential bidders include Procter & Gamble, Sanofi, Johnson & Johnson and Nestle, according to the sources.
4. The auction process will likely extend through next year, with a deal being reached near the middle of 2018, a source told Reuters.
More articles on supply chain:
Pharma’s lobbying efforts: 10 drugmakers that spent the most so far in 2017
FDA announces steps, new guidance to nurture medical device innovations: 4 things to know
Express Scripts sees revenue slip 3% in Q3
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
